Lista de obras - Kirsi Ketola - Dominio Público Uruguay

234 Drugs with known pharmacological profiles, such as monensin, disulfiram and salinomycin, show cancer-selective inhibition of prostate cancer cell growth by increasing oxidative stress

scholarly article by Kirsi Ketola et al published June 2010 in EJC supplements

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

artículo científico publicado en 2013

Abstract 3189: Neuronal transcription factor BRN2 is an androgen suppressed driver of neuroendocrine differentiation in prostate cancer

Abstract 4106: Lyn kinase promotes metastasis through EMT in cancers

Abstract A62: Monensin-induced oxidative stress reduces prostate cancer cell motility and cancer stem cell markers

Abstract C91: Targeting enzalutamide resistance in prostate cancer

Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer

artículo científico publicado en 2011

Axon Guidance-Related Factor FLRT3 Regulates VEGF-Signaling and Endothelial Cell Function

scientific article published on 12 March 2019

BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation

artículo científico publicado en 2020

CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells

scientific article published on 22 March 2019

Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells

artículo científico publicado en 2012

High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion

artículo científico publicado en 2013

High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer

artículo científico publicado en 2016

High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth

artículo científico publicado en 2009

Monensin Induced Oxidative Stress Reduces Prostate Cancer Cell Migration and Cancer Stem Cell Population

Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells

artículo científico publicado en 2010

PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma

artículo científico publicado en 2009

Regulation of tumor cell plasticity by the androgen receptor in prostate cancer

artículo científico publicado en 2015

Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress

artículo científico publicado en 2012

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

artículo científico publicado en 2021

Targeting Lyn regulates Snail family shuttling and inhibits metastasis

artículo científico publicado en 2017

Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition